SEC Form 13F
| Report period | 2026-06-30 |
|---|---|
| Publicly available | 2026-08-14 |
| Reported value | $602,220,442 |
| Positions | 13 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| CRISPR THERAPEUTICS AG | CRSP | NAMEN AKT | $175,652,997 | 3,220,627 |
| WAVE LIFE SCIENCES LTD | WVE | SHS | $106,007,465 | 18,245,691 |
| VIR BIOTECHNOLOGY INC | VIR | COM | $87,134,221 | 8,550,954 |
| BIONTECH SE | BNTX | SPONSORED ADS | $82,798,123 | 889,824 |
| IDEAYA BIOSCIENCES INC | IDYA | COM | $49,693,321 | 1,333,333 |
| CYTOKINETICS INC | CYTK | COM NEW | $29,001,573 | 340,434 |
| LYELL IMMUNOPHARMA INC | LYEL | COM NEW | $21,252,859 | 1,512,659 |
| SPERO THERAPEUTICS INC | SPRO | COM | $20,311,239 | 9,190,606 |
| NKARTA INC | NKTX | COM | $8,916,572 | 3,150,732 |
| FULCRUM THERAPEUTICS INC | FULC | COM | $6,535,713 | 1,785,714 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.